Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Clinical features of amyotrophic lateral sclerosis and other forms of motor neuron disease

Lauren B Elman, MD
Leo McCluskey, MD, MBE
Section Editor
Jeremy M Shefner, MD, PhD
Deputy Editor
John F Dashe, MD, PhD


Amyotrophic lateral sclerosis (ALS), first described by Charcot in the nineteenth century, is a relentlessly progressive, presently incurable, neurodegenerative disorder that causes muscle weakness, disability, and eventually death. ALS is also known as Lou Gehrig's disease, after the famous New York Yankee baseball player who was affected with the disorder [1-3].

ALS has an annual incidence of one to three cases per 100,000 people that is believed to be the same worldwide. There appears to be no ethnic or racial predisposition to ALS. Prior to the age of 65 or 70, the incidence of ALS is higher in men than in women, but thereafter the gender incidence is equal. ALS has an age distribution that peaks in the seventh to eighth decades. However, ALS can occur in people in their twenties. ALS is most commonly sporadic. Genetic or familial ALS represents only 10 percent of all ALS. (See "Familial amyotrophic lateral sclerosis".)

This topic will review the clinical features of ALS. The epidemiology, diagnosis, and differential diagnosis of ALS are discussed separately. (See "Epidemiology and pathogenesis of amyotrophic lateral sclerosis" and "Diagnosis of amyotrophic lateral sclerosis and other forms of motor neuron disease".)


The clinical hallmark of ALS is the combination of upper and lower motor neuron signs and symptoms.

The upper motor neuron findings of weakness with slowness, hyperreflexia, and spasticity result from degeneration of frontal motor neurons located in the motor strip (Brodman area 4) and their axons traversing the corona radiata, internal capsule, cerebral peduncles, pontine base, medullary pyramids, and the lateral corticospinal tracts of the spinal cord. At autopsy, the dorsolateral area of the spinal cord, the region containing the lateral corticospinal tract, is gliotic and hardened or sclerotic to palpation.


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: May 18, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Mitsumoto H, Chad DA, Pioro EP. Amyotrophic lateral sclerosis. In: Contemporary Neurology Series, 49, F.A. Davis Company, Philadelphia 1998.
  2. Rowland LP. Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1998; 160 Suppl 1:S6.
  3. Rowland LP. What's in a name? Amyotrophic lateral sclerosis, motor neuron disease, and allelic heterogeneity. Ann Neurol 1998; 43:691.
  4. Hirano A. Neuropathology of ALS: an overview. Neurology 1996; 47:S63.
  5. Adamek D, Tomik B, Pichór A, et al. The heterogeneity of neuropathological changes in amyotrophic lateral sclerosis. A review of own autopsy material. Folia Neuropathol 2002; 40:119.
  6. Ince PG, Evans J, Knopp M, et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 2003; 60:1252.
  7. Ince PG, Lowe J, Shaw PJ. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 1998; 24:104.
  8. Rowland LP. Amyotrophic lateral sclerosis. Curr Opin Neurol 1994; 7:310.
  9. Kim WK, Liu X, Sandner J, et al. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology 2009; 73:1686.
  10. Rowland LP. Progressive muscular atrophy and other lower motor neuron syndromes of adults. Muscle Nerve 2010; 41:161.
  11. Visser J, van den Berg-Vos RM, Franssen H, et al. Disease course and prognostic factors of progressive muscular atrophy. Arch Neurol 2007; 64:522.
  12. Tsuchiya K, Sano M, Shiotsu H, et al. Sporadic amyotrophic lateral sclerosis of long duration mimicking spinal progressive muscular atrophy exists: additional autopsy case with a clinical course of 19 years. Neuropathology 2004; 24:228.
  13. Singer MA, Statland JM, Wolfe GI, Barohn RJ. Primary lateral sclerosis. Muscle Nerve 2007; 35:291.
  14. Gordon PH, Cheng B, Katz IB, et al. The natural history of primary lateral sclerosis. Neurology 2006; 66:647.
  15. Gordon PH, Cheng B, Katz IB, et al. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology 2009; 72:1948.
  16. D'Amico E, Pasmantier M, Lee YW, et al. Clinical evolution of pure upper motor neuron disease/dysfunction (PUMMD). Muscle Nerve 2013; 47:28.
  17. Chiò A, Calvo A, Moglia C, et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011; 82:740.
  18. Heene R, Kolander D, Knisatschek H. [Chronic progressive spinobulbar spasticity (primary lateral sclerosis)]. Fortschr Neurol Psychiatr 1996; 64:192.
  19. Rowland LP. Primary lateral sclerosis: disease, syndrome, both or neither? J Neurol Sci 1999; 170:1.
  20. Amyotrophic lateral sclerosis and other motor neuron diseases. Adv Neurol 1991; 56:1.
  21. Tan CF, Kakita A, Piao YS, et al. Primary lateral sclerosis: a rare upper-motor-predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degeneration with ubiquitinated neuronal inclusions? Report of an autopsy case and a review of the literature. Acta Neuropathol 2003; 105:615.
  22. Tartaglia MC, Rowe A, Findlater K, et al. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up. Arch Neurol 2007; 64:232.
  23. Donaghy M. Classification and clinical features of motor neurone diseases and motor neuropathies in adults. J Neurol 1999; 246:331.
  24. Hu MT, Ellis CM, Al-Chalabi A, et al. Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1998; 65:950.
  25. Katz JS, Wolfe GI, Andersson PB, et al. Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology 1999; 53:1071.
  26. Couratier P, Truong C, Khalil M, et al. Clinical features of flail arm syndrome. Muscle Nerve 2000; 23:646.
  27. Wijesekera LC, Mathers S, Talman P, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 2009; 72:1087.
  28. Alemà G, Brusa A, Pastorino P, Sacco G. [On 3 cases of the pseudopolyneuritic form of amyotrophic lateral sclerosis. Anatomic and electromyographic study]. J Neurol Sci 1967; 4:241.
  29. McCluskey LF, Elman LB, Martinez-Lage M, et al. Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology. Arch Neurol 2009; 66:121.
  30. Wilbourn AJ. The "split hand syndrome". Muscle Nerve 2000; 23:138.
  31. Kuwabara S, Sonoo M, Komori T, et al. Dissociated small hand muscle atrophy in amyotrophic lateral sclerosis: frequency, extent, and specificity. Muscle Nerve 2008; 37:426.
  32. Eisen A, Kuwabara S. The split hand syndrome in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2012; 83:399.
  33. Shoesmith CL, Findlater K, Rowe A, Strong MJ. Prognosis of amyotrophic lateral sclerosis with respiratory onset. J Neurol Neurosurg Psychiatry 2007; 78:629.
  34. Caress JB, Ciarlone SL, Sullivan EA, et al. Natural history of muscle cramps in amyotrophic lateral sclerosis. Muscle Nerve 2016; 53:513.
  35. Ringholz GM, Appel SH, Bradshaw M, et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005; 65:586.
  36. Rippon GA, Scarmeas N, Gordon PH, et al. An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol 2006; 63:345.
  37. Murphy J, Henry R, Lomen-Hoerth C. Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 2007; 64:330.
  38. Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 2007; 6:994.
  39. Beeldman E, Raaphorst J, Klein Twennaar M, et al. The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry 2016; 87:611.
  40. Woolley SC, Strong MJ. Frontotemporal Dysfunction and Dementia in Amyotrophic Lateral Sclerosis. Neurol Clin 2015; 33:787.
  41. Lomen-Hoerth C, Murphy J, Langmore S, et al. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003; 60:1094.
  42. Massman PJ, Sims J, Cooke N, et al. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1996; 61:450.
  43. Olney RK, Murphy J, Forshew D, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology 2005; 65:1774.
  44. Ng AS, Rademakers R, Miller BL. Frontotemporal dementia: a bridge between dementia and neuromuscular disease. Ann N Y Acad Sci 2015; 1338:71.
  45. Toepfer M, Folwaczny C, Klauser A, et al. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1999; 1:15.
  46. Toepfer M, Folwaczny C, Lochmüller H, et al. Noninvasive (13)C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis. Digestion 1999; 60:567.
  47. Toepfer M, Schroeder M, Klauser A, et al. Delayed colonic transit times in amyotrophic lateral sclerosis assessed with radio-opaque markers. Eur J Med Res 1997; 2:473.
  48. Kihara M, Takahashi A, Sugenoya J, et al. Sudomotor dysfunction in amyotrophic lateral sclerosis. Funct Neurol 1994; 9:193.
  49. Santos-Bento M, de Carvalho M, Evangelista T, Sales Luís ML. Sympathetic sudomotor function and amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2001; 2:105.
  50. Beck M, Giess R, Magnus T, et al. Progressive sudomotor dysfunction in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2002; 73:68.
  51. Kawata A, Kato S, Hayashi H, Hirai S. Prominent sensory and autonomic disturbances in familial amyotrophic lateral sclerosis with a Gly93Ser mutation in the SOD1 gene. J Neurol Sci 1997; 153:82.
  52. Shimizu T, Kawata A, Kato S, et al. Autonomic failure in ALS with a novel SOD1 gene mutation. Neurology 2000; 54:1534.
  53. Geser F, Martinez-Lage M, Robinson J, et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol 2009; 66:180.
  54. Hammad M, Silva A, Glass J, et al. Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology 2007; 69:2236.
  55. Feller TG, Jones RE, Netsky MG. Amyotrophic lateral sclerosis and sensory changes. Va Med Mon (1918) 1966; 93:328.
  56. Isaacs JD, Dean AF, Shaw CE, et al. Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder? J Neurol Neurosurg Psychiatry 2007; 78:750.
  57. Pugdahl K, Fuglsang-Frederiksen A, de Carvalho M, et al. Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study. J Neurol Neurosurg Psychiatry 2007; 78:746.
  58. Amoiridis G, Tsimoulis D, Ameridou I. Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology 2008; 71:779.
  59. Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 2007; 68:1571.
  60. Ravits J, Laurie P, Fan Y, Moore DH. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology 2007; 68:1576.